학술논문
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial
Document Type
Article
Author
Source
In Annals of Oncology October 2016 27(10):1867-1873
Subject
Language
ISSN
0923-7534